Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC-Dutch late effects cohort-linked data.
Juul SJ, Kicinski M, Schaapveld M, Rossetti S, Aleman BMP, Liu L, van Leeuwen FE, Meijnders P, Krol ADG, Janus CPM, Hutchings M, Maraldo MV. Juul SJ, et al. Among authors: krol adg. Eur J Haematol. 2023 Mar;110(3):243-252. doi: 10.1111/ejh.13899. Epub 2022 Nov 25. Eur J Haematol. 2023. PMID: 36369842 Free PMC article. Clinical Trial.
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol AD, Kluin-Nelemans JC, Tirelli U, Monconduit M, Thomas J, Eghbali H, Aleman BM, Bosq J, Vovk M, Verschueren TA, Pény AM, Girinsky T, Raemaekers JM, Henry-Amar M. Noordijk EM, et al. J Clin Oncol. 2006 Jul 1;24(19):3128-35. doi: 10.1200/JCO.2005.05.2746. Epub 2006 Jun 5. J Clin Oncol. 2006. PMID: 16754934 Clinical Trial.
Re: Late effects from radiation therapy: the hits just keep on coming.
Aleman BM, de Bruin ML, Dorresteijn LD, Krol AD, van 't Veer MB, Boogerd W, van Leeuwen FE. Aleman BM, et al. J Natl Cancer Inst. 2010 Apr 21;102(8):576-7; author reply 577-8. doi: 10.1093/jnci/djq069. Epub 2010 Mar 22. J Natl Cancer Inst. 2010. PMID: 20308649 No abstract available.
Risk of multiple primary malignancies following treatment of Hodgkin lymphoma.
van Eggermond AM, Schaapveld M, Lugtenburg PJ, Krol AD, de Boer JP, Zijlstra JM, Raemaekers JM, Kremer LC, Roesink JM, Louwman MW, Aleman BM, van Leeuwen FE. van Eggermond AM, et al. Blood. 2014 Jul 17;124(3):319-27; quiz 466. doi: 10.1182/blood-2013-10-532184. Epub 2014 Apr 16. Blood. 2014. PMID: 24740811 Free article.
Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma.
van Nimwegen FA, Schaapveld M, Janus CP, Krol AD, Raemaekers JM, Kremer LC, Stovall M, Aleman BM, van Leeuwen FE. van Nimwegen FA, et al. J Clin Oncol. 2014 Oct 10;32(29):3257-63. doi: 10.1200/JCO.2013.54.4379. Epub 2014 Aug 25. J Clin Oncol. 2014. PMID: 25154821
Risk of valvular heart disease after treatment for Hodgkin lymphoma.
Cutter DJ, Schaapveld M, Darby SC, Hauptmann M, van Nimwegen FA, Krol AD, Janus CP, van Leeuwen FE, Aleman BM. Cutter DJ, et al. J Natl Cancer Inst. 2015 Feb 23;107(4):djv008. doi: 10.1093/jnci/djv008. Print 2015 Apr. J Natl Cancer Inst. 2015. PMID: 25713164 Free PMC article.
61 results